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Abstract
Chronic inflammation and infection are major risk factors for gastric carcinogenesis in adults. As 
chronic gastritis is common in Mexican children, diagnosis of Helicobacter pylori and other 
causes of gastritis are critical for the identification of children who would benefit from closer 
surveillance. Antral biopsies from 82 Mexican children (mean age 8.3±4.8y) with chronic gastritis 
(36 H. pylori +, 46 H. pylori -) were examined for gastritis activity, atrophy, intestinal metaplasia, 
and immunohistochemical expression of gastric carcinogenesis biomarkers CDX2, ephrin type-B 
receptor 4, matrix metalloproteinase 3 (MMP3), macrophage migration inhibitory factor (MIF), 
p53, β-catenin, and E-cadherin. Atrophy was diagnosed in 7/82 (9%) and intestinal metaplasia in 
5/82 (6%) by routine histology, while 6 (7%) additional children (3 H. pylori +) exhibited aberrant 
CDX2 expression without intestinal metaplasia. Significant positive correlations were seen 
between EphB4, MMP3, and MIF (p<0.0001). Atrophy and follicular pathology were more 
frequent in H. pylori + biopsies (p<0.0001), while intestinal metaplasia and CDX2 expression 
showed no significant correlation with H. pylori status. Antral biopsies demonstrating atrophy, 
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intestinal metaplasia, and/or aberrant CDX2 expression were seen in 21.95 % (18/82) of the 
children, potentially identifying those who would benefit from closer surveillance and preventive 
dietary strategies. Biomarkers CDX2, EphB4, MMP3, and MIF may be useful in the work-up of 
pediatric gastritis.
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Introduction
Chronic inflammation is a risk factor for carcinogenesis in several tissues, including the 
stomach1, 2. Inflammation is a well-coordinated response of the innate and adaptive immune 
systems following infection or injury1. Deregulation of the inflammatory response leads to 
unresolved inflammation and a pro-neoplastic microenvironment1. The tissue damage 
produced by high levels of phagocyte-generated reactive oxygen, nitrogen, and halogen 
species can cause mutations and cell death and play a key role in the carcinogenic process2.
Chronic gastritis in children has multiple etiologies, including gastroesophageal reflux, food 
allergies, high intake of spicy food, acid peptic disease, non-steroidal anti-inflammatory 
drugs, and Helicobacter pylori infection. H. pylori infection increases the production of 
reactive oxygen and nitrogen species, and the gram-negative microaerophile confers nearly 
an eleven-fold increased risk of gastric cancer (GC)3. Infection with H. pylori is highly 
prevalent among socially and economically disadvantaged children. Age, overcrowding, 
number of siblings, and a low maternal education level increase infection risk4-7.
Globally, GC is the fourth most common cancer and second highest cause of cancer 
mortality with nearly two-thirds of these deaths occurring in developing nations3. Although 
we seldom see GC in children, these issues are of keen interest in underdeveloped countries 
where H. pylori is highly prevalent. Gastric carcinogenesis is hypothesized to be a process 
involving a number of premalignant genetic and morphologic alterations of gastric mucosa. 
Busuttil and Boussioutas3 outline the progression from normal stomach to gastritis, and 
intestinal metaplasia (IM). IM is considered a preneoplastic lesion, although it should be 
noted not all IM advances to dysplasia, the step previous to GC8,9.
Given the important role of chronic inflammation in carcinogenesis, we sought to determine 
whether Mexican children with a pathologic diagnosis of chronic antral gastritis exhibited 
histologic markers associated with adult preneoplastic lesions. Secondly, since Caudal Type 
Homeobox 2 (CDX2) expression precedes the development of gastric preneoplastic lesions 
in the setting of IM, we sought to define the H. pylori status and expression of CDX2 in our 
cohort of children and compare them with Mexican and American adult cohorts. Finally, we 
seek a panel of candidate biomarkers to use routinely in gastric biopsies in pediatric 
populations with a high prevalence of H. pylori infection7. Therefore, we selected an 
immunohistochemical (IHC) protein profile involved in gastric carcinogenesis and 
progression: Caudal Type Homeobox 2 10, Ephrin Type-B Receptor 4 (EphB4)11-12, Matrix 
Metalloproteinase 3 (MMP3)13-14, Macrophage Migration Inhibitory Factor (MIF)15, p53 
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(TP53 tumor ressor gene)16, β-catenin, and E-cadherin17-18. Our ultimate goal is the 
identification of children with antral lesions who would benefit from closer follow up 
surveillance, preventive nutritional strategies, and health promotion activities.
Materials and Methods
Patients and Samples
This study was conducted with the approval of the Central Military Hospital and the 
Medical College of Wisconsin Institutional Review Board (IRB). Consecutive gastric antral 
biopsy samples were obtained from 82 Mexican children (Table 1) of middle socioeconomic 
status attending the Central Military Hospital in Mexico City the first 3 months of 1996 and 
2009.
Patients presented with one or more of the following symptoms: chronic epigastric or 
abdominal pain, pyrosis, or gastrointestinal bleeding. Gastroesophageal junction, antrum, 
and duodenum biopsies were examined by an attending hospital pathologist. Our cases did 
not include autoimmune gastritis, chemical gastritis, primary bile reflux gastritis, inadvertent 
sampling of the gastroduodenal junction, or postoperative gastritis, and none had received H. 
pylori eradication therapy. The adult biopsies were used as controls to compare CDX2 and 
the gastritis criteria with the children’s biopsy results. Thirty-five adult antral specimens 
were obtained from either Froedtert Hospital in Milwaukee, WI (n=14) or the Mexican 
Institute of Social Security (n=21) (Table 1).
Immunohistochemical Staining
Biopsy specimens were fixed in 10% buffered formalin and embedded in paraffin. Four 
micrometer thick sections were deparaffinized in xylene, hydrated in descending dilutions of 
ethanol, and exposed to heat-induced epitope retrieval. See Table 2 for details.
Pediatric CDX2 and p53 IHC staining was performed manually. IHC for β-catenin, E-
cadherin, adult CDX2, EphB4, MIF, MMP3, and H. pylori was performed using reagents 
from the Dako Envision FLEX High pH kit and the Dako Autostainer Plus. Following 
pretreatment with Target Retrieval Solution (TRS pH 9.0), tissue was blocked with 
peroxidase-blocking reagent for 5 min, treated with PBS/BSA (EphB4, MIF, MMP3) for 30 
min, incubated with primary antibody for 10 min (CDX2) or 30 min (β-catenin, E-cadherin, 
EphB4, MIF, MMP3) at room temperature, followed by 20 min horseradish peroxidase, 10 
min DAB, and EnVision FLEX hematoxylin (Dako, Carpinteria, CA, US) counterstain.
Immunohistochemistry Analysis
The percentage of total gastric gland epithelial cells staining positive was determined 
(EphB4, MIF, MMP3). The samples were analyzed by a pathologist (ACM and/or ALG) 
blind to gastritis parameter scores or H. pylori infection status. To validate IHC, we stained 
various adult tissue specimens. These staining patterns were used as reference intensities for 
the gastric staining and scoring. β -catenin, E-cadherin, and CDX2 were scored as either 1 
(low) or 2 (high) staining intensity. β-catenin expression was evaluated in membranous or 
nuclear location. Staining intensity for EphB4, MIF, and MMP3 was determined as: 0 
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(none), 1 (mild), 2 (moderate), and 3 (strong). The most intense stain covering at least 10% 
of the biopsy was used as the intensity score. p53 was evaluated based on presence of 
nuclear positivity. Positive control tissues included: breast cancer (p53), colon (β-catenin, E-
cadherin, EphB4), duodenum (CDX2), and liver (MIF, MMP3).
Four criteria of chronic gastritis—gastritis activity, atrophy, follicular pathology, and IM—
were evaluated by a pathologist (ALG). Histological classification of all biopsies’ H&E 
stains was done according to the Updated Sidney System19.
Warthin-Starry stain was used for the detection of H. pylori in the U.S.A. adult samples. A 
modified Giemsa stain was used to detect H. pylori in the specimens from the Mexican 
children and adults. All pediatric samples that were H. pylori negative were confirmed with 
H. pylori IHC.
Statistical Analysis
Statistical analyses were performed using SAS 9.2 Statistical software. The correlation 
between the antibodies and gastritis parameters was measured by Spearman Rank-order test. 
The association between H. pylori status and gastritis criteria was investigated by Pearson 
Chi-square test. The association of antibody staining intensities with H. pylori infection 
status as well as the association of CDX2 with H. pylori infection status for children and 
adults was tested by Fisher’s exact test. Significance was set at p <0.05.
Results
The distribution of selected gastritis histopathology and immunohistochemistry variables in 
the pediatric cohort is shown in Table 3. Antral atrophy was seen in 7/82 (8.5%) and IM in 
5/82 (6.1 %) by H&E staining (Figure 3). The IM was classified as Type I for 4/5 cases and 
type II for the fifth case20. Of the 7 children with atrophy, 6 had H. pylori + biopsies, while 
of the 5 children with IM, one was H. pylori +.
Expression of β-catenin and E-cadherin expression occurred in 96% and 100% of cases 
respectively and was membranous (Figure 1). There was no nuclear β-catenin staining. No 
biopsies exhibited p53 nuclear positivity. Six additional biopsies exhibited aberrant CDX2 
expression without histologic evidence of IM (Figure 1), and CDX2 expression did not 
correlate with H. pylori infection. Expression of MMP3, EphB4, and MIF was present in 
96%, 90% and 62 % of biopsies, respectively (Figure 2). There was a positive correlation 
between cases with EphB4 positivity and MMP3 and MIF positivity (p<0.0001).
Significant negative correlations were noted between the severity of gastritis activity and 
MMP3 (p=0.0255) and EphB4 (p=0.0432), as well as between atrophy and MMP3 percent 
positivity (p=0.0370).
H. pylori Positive and H. pylori Negative Children Groups
In children, H. pylori positive versus negative biopsies differed significantly with respect to 
atrophy (Chi-square 56.5744, Asymptotic Pr>Chi-Sq p<0.0001) and follicular pathology 
(Chi-square 11.3981, Asymptotic Pr>Chi-Sq p<0.0007), but not with respect to IM (Chi-
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square 1.2353, Asymptotic Pr>Chi-Sq p=0.2664). Membranous β-catenin intensity was 
significantly higher in biopsies from H. pylori positive patients compared with those from H. 
pylori negative patients (p=0.0026). In H. pylori positive biopsies, negative correlations 
were noted between MMP3 and atrophy (p=0.0484) and EphB4 and gastritis activity 
(p=0.0475). In H. pylori negative biopsies, MMP3 staining correlated negatively with 
atrophy (p=0.0256) and gastritis activity (p=0.0015).
CDX2 Expression: Child and Adult
CDX2 was positive in 6 (7%) of children’s gastric biopsy specimens (3 H. pylori + and 3 H. 
pylori -), and exhibited no significant associations with any of the gastritis criteria. CDX2 
expression was more frequent in adult biopsies than in children’s biopsies regardless of 
infection status (p<0.0001), as well as within H. pylori + (p=0.0122) and H. pylori - 
(p<0.0001) adult cohorts. Adult CDX2 percent positivity showed significant positive 
correlations with both IM (p=0.0019) and atrophy (p=0.0433).
Discussion
We found that 18 of 82 antral biopsies from children had either atrophy, intestinal 
metaplasia (IM), and/or ectopic CDX2 expression. This is notable considering that IM and 
atrophy are relatively rare in other reported studies of pediatric gastritis6,21, 22. As CDX2 is 
expressed early in the IM progression pathway, ectopic antral CDX2 probably reflects 
pathologic changes leading to IM3. In transgenic mice, gastric expression of CDX2 alone 
can induce IM25. Children’s biopsies had significantly less CDX2 positivity than adults’ 
biopsies, regardless of infection status. Adults also showed a significant positive correlation 
of CDX2 with both IM and atrophy. In contrast, children’s biopsies with CDX2 positivity 
exhibited no significant associations with these two gastritis parameters or with H. pylori 
status. Current literature suggests IM regression is rare. While elimination of H. pylori is 
associated with regression of gastric inflammation and atrophy, IM usually persists23. Since 
80% of gastric carcinomas arise in the context of IM and its presence results in a two to six-
fold increased risk for cancer development23,26, the finding of CDX2 positivity in 7% of 
children warrants further exploration for its association with either H. pylori or other chronic 
gastritis etiologies.
As the regulatory mechanisms involved in triggering and maintaining gastric CDX2 
expression are not entirely clear27, we were interested in two recent papers describing novel 
CDX2 regulatory mechanisms relevant to this work. Barros et al. suggested an auto-
regulatory CDX2 loop, which may have a major impact on the stability of human IM, 
possibly resulting in progression along the gastric carcinogenesis pathway23. Results from 
Camilo et al. provided a link between H. pylori infection and the Bone Morphogenetic 
Protein (BMP) pathway in the regulation of intestinal and gastric-specific genes that might 
be relevant for gastric IM24. It remains to be seen what CDX2 regulatory mechanisms 
participate in the absence of H. pylori25-28.
Atrophy exhibited a strong correlation with H. pylori positive status in our children. Chronic 
atrophic gastritis has been considered a progressive disease worsened by H. pylori infection, 
use of non-steroidal anti-inflammatory drugs and proton pump inhibitors, and with the 
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intake of carbonated drinks and fast food29. This is relevant to our cohort’s diet and high 
consumption of soft drinks in Mexico—an average of 163 L per capita per year compared to 
118L in the U.S.A.).30
The significant positive associations between EphB4, MMP3, and MIF (p<0.0001) suggest 
interaction between the EphB pathway which regulates the degradation of extracellular 
matrix proteins, cell adhesion proteins, and an inflammatory cytokine in the progression 
from chronic inflammation to carcinogenesis. EphB4 is part of the Eph (erythropoietin-
producing hepatoma) receptor tyrosine kinase family regulating cell migration during 
embryonic development and adhesion and migration of cancer cells. It is fundamental for 
angiogenesis, vessel maturation, and pericyte recruitment11. It has been consistently found 
in most epithelial cancers, including gastric cancer12. The expression of EphB4 in 90% of 
antral samples is pertinent to the recently emerging unifying theme outlined in Wang et al., 
in which an evolving cancer cell may either directly eliminate the anti-migratory effects of 
the activated Eph receptors, or the Eph receptors aid in migration and invasion31. This novel 
concept is highly relevant in the setting of gastric carcinogenesis because epithelial cells 
with high expression of Ephs and ephrins could have a survival advantage and participate in 
the tumor progression selection31. The persistence of high EphB4 immunoreactivity in 
gastric glands in the scenario of IM and gastric atrophy raises questions about malignant 
progression, particularly if the high expression is not ameliorated by treatment31,32.
MMP3 upregulation has also been associated with gastric carcinogenesis13,14. In the 
Economescu et al. study13, MMP3 upregulation was associated with gastric tumor 
progression, while Rajkumar et al. 14 demonstrated MMP3 upregulation in gastric 
carcinomas but not in the adjacent non-neoplastic gastric mucosa. Moreover, MMP3 
promoter polymorphisms (MMP3707 G/G and MMP3-1612 5A/6A) are potential 
independent predictors of gastric cancer risk development33.
Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine which plays 
important roles in inflammation and tumorigenesis. Polymorphisms such as MIF-173 and 
MIF-794-CATT have been associated with risk for severe chronic atrophic gastritis34. Mice 
studies have found both serum and gastric MIF immunoexpression progressively increase in 
H. pylori-induced gastritis, IM, and gastric cancer, and even in gastric injury due to non-
steroidal anti-inflammatory drugs35,36. Fehlings et al. demonstrated that MIF suppression by 
H. pylori infected monocyte-derived dendritic cells enables immune evasion mechanisms, 
promoting the bacterium’s persistence37. MIF knockout mice, on the other hand, did not 
develop gastritis after H. pylori infection—the inhibition of H. pylori-induced innate 
immune responses and Th1 -- mediated immune injury playing a probable role38. Given the 
uncertainty of the role of MIF in pediatric antral biopsies, this marker should be further 
explored in the evaluation of these specimens.
High membranous β-catenin expression was significantly associated with H. pylori positive 
biopsies, while E-cadherin expression was not associated with H. pylori status. Infection 
with H. pylori is associated with deregulated accumulation of nuclear β-catenin and 
promotes malignant transformation, while mutations of CTNNB1 genes occur early in GC 
development and contribute to gastric carcinogenesis18,39. The Wnt/ β-catenin pathway, 
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among its many vital developmental roles, is also involved in the development of cancer and 
in supporting cadherin-mediated cell adhesion40. It will be of interest to expand this 
observation to larger cohorts, and especially with longitudinal follow-up. H. pylori-induced 
calpain activation results in cleavage of E-cadherin to produce a truncated form and induce 
relocalization of E-cadherin and β-catenin and inhibition of TLR2 prevented H. pylori-
induced calpain activation and adherens junctions (AJ) disassembly41. O′Connor suggested 
H. pylori activates calpain via TLR2 to disrupt gastric epithelial AJ structure—in turn, the 
disruption of AJ structure favors severe disease41.
The presence of atrophy, IM and CDX2 positive cells independent of H. pylori status 
suggest a need for more intense clinical surveillance in this pediatric cohort. Close follow-up 
should be indicated for children with CDX2 nuclear positivity even in the absence of 
intestinal metaplasia by H&E, high expression of EphB4 31, and those with atrophy. 
Biopsies with atrophy should be checked for H. pylori by modified Giemsa, Warthin-Starry, 
or H. pylori antibodies. Moreover, since intestinal metaplasia rarely regresses and there are 
no published children’s studies indicating the natural history of IM, follow-up is warranted.
Alongside the follow-up pathology and clinical surveillance, use of probiotics42,43, avoiding 
the use of unnecessary antibiotics that wipe out beneficial bacteria44, preventive dietary 
strategies i.e., diets high in vegetables and reduced intake of carbonated drinks and spicy 
food29, along with health promotion activities (i.e., introduction of free, potable drinking-
water fountains in schools and public spaces, educating parents on improving sanitation 
conditions, and nutritional guidance to mothers) should be encouraged.
The importance of our findings is limited by the absence of long-term clinical and 
pathologic follow-up. Expanding the number of cases and having access to sequential 
biopsies will allow us to define the progression of the preneoplastic lesions and the use of 
selected markers in future studies. Prospective studies of pediatric antral biopsies would 
benefit from differential gene expression profiling of key markers using laser 
microdissection a45, and the use of DNA microarrays of preneoplastic lesions. Longitudinal 
studies plus molecular techniques will disclose the complex interplay of environmental and 
genetic factors in the development of gastric preneoplastic lesions in children.
Acknowledgments
The Federation of American Societies for Experimental Biology (FASEB), the American Society for Investigative 
Pathology (ASIP) and their Minority Access to Research Careers (MARC) Summer Research Opportunities 
Program in Pathology (SROPP) generously supported Rodolfo Villarreal-Calderon to conduct research for this 
study at the Medical College of Wisconsin in Milwaukee, WI under the mentorship of Dr. Alexander Craig 
Mackinnon, Jr. This project was supported, in part, by grant 1UL1RR031973 from the Clinical and Translational 
Science Award (CTSI) program of the National Center for Research Resources, NIH, which allowed for the 
biostatistics work at the Medical College of Wisconsin Institute for Health and Society, with the help of Assistant 
Professor Dr. Sergey Tarima.
References
1. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 
2007; 121:2373–2380. [PubMed: 17893866] 
Villarreal-Calderon et al. Page 7













2. Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling 
chemical mechanisms and biological fates. Int J Cancer. 2011; 128:1999–2009. [PubMed: 
21387284] 
3. Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric 
carcinogenesis. J Gastroenterol Hepatol. 2009; 24:193–201. [PubMed: 19215332] 
4. Muñoz L, Camorlinga M, Hernandez R, et al. Immune and proliferative cellular responses to 
Helicobacter pylori infection in the gastric mucosa of Mexican children. Helicobacter. 2007; 
12:224–230. [PubMed: 17493002] 
5. Vilchis J, Duque X, Mera R, et al. Association of Helicobacter pylori infection and height of 
Mexican children of low socioeconomic level attending boarding schools. Am J Trop Med Hyg. 
2009; 81:1091–1096. [PubMed: 19996442] 
6. Jaramillo-Rodríguez Y, Nares-Cisneros J, Martínez-Ordaz VA, et al. Chronic gastritis associated 
with Helicobacter pylori in Mexican children: histopathological patterns. Pediatri Dev Pathol. 2011; 
14:93–98.
7. Duque X, Vilchis J, Mera R, et al. Natural history of Helicobacter pylori infection in Mexican 
school children: Incidence and spontaneous clearance. J Pediatr Gastroenterol Nutr. 2012; 55:209–
216. [PubMed: 22227999] 
8. Rugge M, Capelle LG, Cappellesso R, et al. Precancerous lesions in the stomach: from biology to 
clinical patient management. Best Pract Res Clin Gastroenterol. 2013; 27:205–223. [PubMed: 
23809241] 
9. Zheng Y, Wang L, Zhang JP, et al. Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia 
and gastric carcinoma. World J Gastroenterol. 2010; 16:339–344. [PubMed: 20082479] 
10. Goto A, Hirahashi M, Osada M, et al. Aberrant activation-induced cytidine deaminase expression 
is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Arch. 
2011; 458:717–724. [PubMed: 21538122] 
11. Salvuci O, Tosato G. Essential role of EphB receptors and EphrinB ligands in endothelial cell 
function and angiogenesis. Adv Cancer Res. 2012; 114:21–57. [PubMed: 22588055] 
12. Li M, Zhao ZW, Zhang Y, et al. Over-expression of Ephb4 is associated with carcinogenesis of 
gastric cancer. Dig Dis Sci. 2011; 56:698–706. [PubMed: 20686847] 
13. Economescu MC, Necula LG, Dragu D, et al. Identification of potential biomarkers for early and 
advanced gastric adenocarcinoma detection. Hepatogastroenterology. 2010; 57:1453–1464. 
[PubMed: 21443102] 
14. Rajkumar T, Vijayalakshmi N, Gopal G, et al. Identification and validation of genes involved in 
gastric tumorigenesis. Cancer Cell Int. 2010; 10:45. [PubMed: 21092330] 
15. Salminen A, Kaarniranta K. Control of p53 and NF-kappaB signaling by WIP1 and MIF: role in 
cellular senescence and organismal aging. Cell Signal. 2011; 23:747–752. [PubMed: 20940041] 
16. Gonçalves AR, Carneiro AJ, Martins I, et al. Prognostic significance of p53 protein expression in 
early gastric cancer. Pathol Oncol Res. 2011; 17:349–355. [PubMed: 21116760] 
17. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a 
specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA. 
1990; 87:4246–4250. [PubMed: 2349235] 
18. Udhayakumar G, Jayanthi V, Devaraj N, et al. Nuclear translocation of beta-catenin correlates with 
CD44 upregulation in Helicobacter pylori-infected gastric carcinoma. Mol Cell Biochem. 2011; 
357:283–293. [PubMed: 21678082] 
19. Dixon, MF.; Genta, RM.; Yardley, JH., et al. Classification and grading of gastritis. The updated 
Sydney System. Am J Surg Pathol; International Workshop on the Histopathology of Gastritis, 
Houston 1994; 1996. p. 1161-1181.
20. Jass JR, Filipe MI. A variant of intestinal metaplasia associated with gastric carcinoma: a 
histochemical study. Histopathology. 1979; 3:191–199. [PubMed: 468122] 
21. Carvalho MA, Machado NC, Ortolan EV, et al. Upper gastrointestinal histopathological findings in 
non-ulcer dyspeptic children and adolescents with Helicobacter pylori infection. J Pediatric 
Gastroenterol Nutr. 2012; 55:523–529.
Villarreal-Calderon et al. Page 8













22. Hoepler W, Hammer K, Hammer J. Gastric phenotype in children with Helicobacter pylori 
infection undergoing upper endoscopy. Scand J Gastroenterol. 2011; 46:293–298. [PubMed: 
21073375] 
23. Barros R, da Costa LT, Pinto-de-Sousa J, et al. CDX2 autoregulation in human intestinal 
metaplasia of the stomach: impact on the stability of the phenotype. Gut. 2011; 60:290–298. 
[PubMed: 21148572] 
24. Camilo V, Barros R, Sousa S, et al. Helicobacter pylori and the BMP pathway regulate CDX2 and 
SOX2 expression in gastric cells. Carcinogenesis. 2012; 33:1985–1992. [PubMed: 22791809] 
25. Silberg DG, Sullivan J, Kang E, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia 
in transgenic mice. Gastroenterology. 2002; 122:689–696. [PubMed: 11875002] 
26. Asfeldt AM, Steigen SE, Lochen ML, et al. The natural course of Helicobacter pylori infection on 
endoscopic findings in a population during 17 years of follow-up: the Sorreisa gastrointestinal 
disorder study. Eur J Epidemiol. 2009; 24:649–658. [PubMed: 19629722] 
27. de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with 
premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 
2008; 134:945–952. [PubMed: 18395075] 
28. Barros R, Pereira B, Duluc I, et al. Key elements of the BMP/SMAD pathway co-localize with 
CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines. J Pathol. 
2008; 215:411–420. [PubMed: 18498120] 
29. Chooi EY, Chen HM, Miao Q, et al. Chronic atrophic gastritis is a progressive disease: analysis of 
medical reports from Shanghai 1985-2009. Singapore Med J. 2012; 53:318–324. [PubMed: 
22584971] 
30. Mexico Leads World in Consumption of Sugary Drinks, Study Says. Health. 2011. Retrieved from 






31. Wang B. Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of 
unwitting partners. Sci Signal. 2011; 4(175):pe28. [PubMed: 21632467] 
32. Noren NK, Pasquale EB. Paradoxes of the EphB4 receptor in cancer. Cancer Res. 2007; 67:3994–
3997. [PubMed: 17483308] 
33. Dey S, Stalin S, Gupta A, et al. Matrix metalloproteinase 3 gene promoter polymorphisms and 
their haplotypes are associated with cancer risk in eastern Indian population. Mol Carcinog. 2012; 
51(Suppl 1):E42–53. [PubMed: 22121090] 
34. Li ZW, Wu Y, Sun Y, et al. Inflammatory cytokine gene polymorphisms increase the risk of 
atrophic gastritis and intestinal metaplasia. World J Gastroenterol. 2010; 16:1788–1794. [PubMed: 
20380014] 
35. He XX, Yang J, Ding YW, et al. Increased epithelial and serum expression of macrophage 
migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. 
Gut. 2006; 55:797–802. [PubMed: 16488898] 
36. Ohkawara T, Takeda H, Ohnishi S, et al. Macrophage migration inhibitory factor contributes to 
development of nonsteroidal anti-inflammatory drugs-induced gastric injury in mice. Int 
Immunopharmacol. 2011; 11:418–423. [PubMed: 21185918] 
37. Fehlings M, Drobbe L, Moos V, et al. Comparative analysis of the interaction of Helicobacter 
pylori with human dendritic cells, macrophages and monocytes. Infect Immun. 2012; 80:2724–
2734. [PubMed: 22615251] 
38. Wong BL, Zhu SL, Huang XR, et al. Essential role for macrophage migration inhibitory factor in 
gastritis induced by Helicobacter pylori. Am J Pathol. 2009; 174:1319–1328. [PubMed: 19286569] 
39. Jang BG, Kim WH. Molecular pathology of gastric carcinoma. Pathobiology. 2011; 78:302–310. 
[PubMed: 22104201] 
40. Archbold HC, Yang YX, Chen L, et al. How do they do Wnt they do?: regulation of transcription 
by the Wnt/beta-catenin pathway. Acta Physiol. 2011; 204:74–109.
Villarreal-Calderon et al. Page 9













41. O’Connor PM, Lapointe TK, Jackson S, et al. Helicobacter pylori activates calpain via toll-like 
receptor 2 to disrupt adherens junctions in human gastric epithelial cells. Infect Immun. 2011; 
79:3887–3894. [PubMed: 21825064] 
42. Vitor JM, Vale FF. Alternative therapies for helicobacter pylori: probiotics and phytomedicine. 
FEMS Immunol Med Microbiol. 2011; 63:153–164. [PubMed: 22077218] 
43. Yang YJ, Sheu BS. Probiotics-containing yogurts suppress Helicobacter pylori load and modify 
immune response and intestinal microbiota in the Helicobacter pylori-infected children. 
Helicobacter. 2012; 17:297–304. [PubMed: 22759330] 
44. Blaser M. Antibiotic overuse: Stop the killing of beneficial bacteria. Nature. 2011; 476:393–394. 
[PubMed: 21866137] 
45. Kouznetsova I, Kalinski T, Meyer F, et al. Self-renewal of the human gastric epithelium: new 
insights from expression profiling using laser microdissection. Mol Biosyst. 2011; 7:1105–1112. 
[PubMed: 21240392] 
Villarreal-Calderon et al. Page 10













Figure 1. β-catenin, E-cadherin, & CDX2 (400x)
(A) Unremarkable antral biopsy from four-year-old girl, H&E. (B) β-catenin. Membranous 
positivity is weak with a patchy distribution. (C) 6 month old girl with H. pylori positive 
biopsy and focal glandular atrophy, H&E. (D) β-catenin. The membranous positivity is 
strong. There is no nuclear positivity. (E) Fifteen-year-old boy with active severe 
inflammatory response and H pylori positivity, H&E. Elsewhere in the biopsy there was 
focal atrophy and follicular pathology. (F) E-cadherin. Weak focal membranous 
immunoreactivity. (G) Fifteen-year-old-boy with abdominal pain and a finely granular 
gastric mucosa at endoscopy, H&E. Mild chronic inflammation and elsewhere follicular 
pathology. (H) E-cadherin. Strongly positive membranous staining. (I) Eight-year-old girl 
with an unremarkable, H. pylori negative antral biopsy, H&E. (J). CDX2. Positive weak 
nuclear staining in mostly dilated gastric glands. (K) Fifty-nine-year old with H. pylori 
positive biopsy and intestinal metaplasia, H&E. (L) CDX2. Nuclear immunoreactivity is 
strong in the area of intestinal metaplasia.
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Figure 2. EphB4, MMP3, & MIF (400x)
(A) Eight-year-old girl with a history of abdominal pain and H. pylori positive biopsy. 
Moderately active gastritis, H&E. (B) EphB4. Weak immunoreactivity of EphB4 in gastric 
glands surrounded by focal severe chronic inflammatory infiltrates. Inset shows a 
hyperplastic follicle H&E × 200. (C) Nineteen month-old boy with a history of abdominal 
pain, normal gastric mucosa at endoscopy and negative H. pylori. Mild inflammation, H&E. 
(D) EphB4. Moderate immunoreactivity is seen in glands surrounded by mild inflammatory 
activity. (E) Eight year old girl, biopsy negative for H. pylori. Mild inflammatory activity, 
H&E. (F) EphB4. Strong EphB4 immunoreactivity is seen in glands surrounded by mild 
inflammation.
(G) Twelve year old girl with a history of chronic abdominal pain, mild gastritis by 
endoscopy and antral biopsy positive for H pylori. Mild inflammatory activity, H&E. (H) 
MMP3. Scattered glands with weak cytoplasmic staining. (I) Three year old boy with a 
clinical history of chronic abdominal pain, mild gastritis by endoscopy. and antral biopsy 
positive for H. pylori, H&E. There is mild inflammatory activity. (J) MMP3. A moderate 
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number of gastric glands showed cytoplasmic immunoreactivity. (K) Seventeen-year-old 
girl with a normal endoscopy and positive H. pylori. Mild inflammatory activity, H&E. (L) 
MMP3. Strong immunoreactivity of gastric epithelial cells in association with moderate 
focal chronic inflammation. (M) Nine-year-old girl with H. pylori positive biopsy. Mild 
inflammation, H&E. (N) MIF. Scattered MIF-positive glands. (O) Eight-year-old girl with a 
history of abdominal pain and a granular antral biopsy at endoscopy. Moderate 
inflammation, H&E. Inset: hyperplastic follicle. (P) MIF. Moderate cytoplasmic MIF 
staining. (Q) MIF control with strong positivity.
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Figure 3. Representative pediatric gastric biopsies showing gastritis criteria
(A) Normal follicles. (B) Hyperplastic follicles. (C) Absent atrophy. (D) Atrophy present. 
(E) Absent inflammation. (F) Mild inflammation. (G) Moderate inflammation.
(H) Marked inflammation. (I) Absent intestinal metaplasia. (J) Incomplete intestinal 
metaplasia.
(K) Complete intestinal metaplasia.
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Table 1
Patient age, gender, and Helicobacter pylori status
Variables Children (n: 82) Adults (n: 35)
Age [mean years (range)] 8.1 (0.3 to 17) 66.3 (50 to 81)
Gender (female, male) 47, 35 18, 17
H. pylori (+, -) 36, 46 21, 14
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Table 2
Antibodies and pretreatment used
Antigen Clone Source HIER* Dilution
β-Catenin β-Catenin-1 Dako TRS pH 9.0 RTU**
CDX2 (children) AMT28 Leica Microsystems Citrate buffer pH 6.0 1/100
CDX2 (adults) DAK-CDX2 Dako TRIS pH 9 RTU
E-Cadherin NCH-38 Dako TRIS pH9 RTU
EphB4 3D7G8 InVitrogen TRIS pH9 1/50
H. pylori Rabbit Dako Citrate pH 6 RTU
MIF D-2 Santa Cruz Biotech TRIS pH 9 1:200
MMP3 10D6 R&D Systems TRIS pH 9 1:50




RTU: Ready to use
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Table 3
Histopathologic and immunostain findings in pediatric cohort (n=82)
Variable Score n %
Gastritis 0 (No Activity) 39 47.6
1 (Mild) 30 36.6
2 (Moderate) 6 7.3
3 (Strong) 7 8.5
Atrophy * No 75 91.5
Yes 7 8.5
Follicular pathology * none 70 85.4
Mild 11 13.4
Marked 1 1.2
Intestinal metaplasia * No 77 93.9
Yes 5 6.1
H pylori Negative 46 56.1
Positive 36 43.9
p53 Negative 82 100
CDX2 Low 76 92.7
High 6 7.3
MIF 0 30 34.2
1+ 45 55.7
2+ 5 6.3








β-catenin, membranous 0 3 4.0
1+ 46 60.5
2+ 27 35.5
E-cadherin 1+ 8 10.1
2+ 71 89.9
*
Four criteria of chronic— gastritis gastritis activity, atrophy, follicular pathology, and intestinal metaplasia were evaluated according to the 
Updated Sidney System.
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